Koninklijke Philips (NYSE:PHG) Receives Average Rating of “Moderate Buy” from Analysts

Koninklijke Philips (NYSE:PHG) has been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company.

A number of research analysts have recently issued reports on PHG shares. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. Finally, BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th.

Koninklijke Philips Trading Down 1.3 %

PHG opened at $23.31 on Tuesday. The business has a fifty day simple moving average of $25.38 and a 200-day simple moving average of $26.57. Koninklijke Philips has a 52 week low of $19.61 and a 52 week high of $32.91. The firm has a market cap of $21.91 billion, a P/E ratio of -27.75, a P/E/G ratio of 0.82 and a beta of 0.81. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The firm had revenue of $5.38 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, equities analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be given a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio is currently -89.29%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Colonial Trust Co SC lifted its position in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company’s stock valued at $36,000 after acquiring an additional 1,238 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Koninklijke Philips during the 3rd quarter valued at about $54,000. Farther Finance Advisors LLC grew its position in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after acquiring an additional 582 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in Koninklijke Philips during the fourth quarter worth $55,000. Finally, Millstone Evans Group LLC acquired a new position in Koninklijke Philips during the fourth quarter valued at approximately $60,000. 13.67% of the stock is owned by institutional investors and hedge funds.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.